During the last session, OKYO Pharma Limited (NASDAQ:OKYO)’s traded shares were 87998.0, with the beta value of the company hitting -0.26. At the end of the trading day, the stock’s price was $2.25, reflecting an intraday gain of 1.81% or $0.04. The 52-week high for the OKYO share is $3.11, that puts it down -38.22 from that peak though still a striking 64.0% gain since the share price plummeted to a 52-week low of $0.81. The company’s market capitalization is $76.25M, and the average trade volume was 141.40K shares over the past three months.

OKYO Pharma Limited (OKYO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. OKYO has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.

OKYO Pharma Limited (NASDAQ:OKYO) trade information

OKYO Pharma Limited (OKYO) registered a 1.81% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.81% in intraday trading to $2.25, hitting a weekly high. The stock’s 5-day price performance is -3.43%, and it has moved by 40.89% in 30 days. Based on these gigs, the overall price performance for the year is 72.01%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -126.59%. While earnings are projected to return 57.50% in 2025.

OKYO Dividends

OKYO Pharma Limited is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

OKYO Pharma Limited (NASDAQ:OKYO)’s Major holders

OKYO Pharma Limited insiders own 34.41% of total outstanding shares while institutional holders control 6.13%, with the float percentage being 9.35%.